New York Headache blog

by Dr. Alexander Mauskop
January 24, 2023
I am speaking on refractory migraines at the Winter HCNE Headache Symposium
January 24, 2023
Another excellent educational course for healthcare professionals will be held on March 10th and 11th in Greenwich, CT. The Headache Cooperative of New England has held these symposia for over 20 years. The topic of my...
Read article
January 21, 2023
Dr. Lisa Gfrerer to speak on migraine surgery at the NY Headache Club meeting on January 25
January 21, 2023
Migraine surgery is controversial. I would not consider it until most of the less invasive options have been tried. In my latest book, I give migraine surgery a score of 3, on a 1 to 10 scale. This rating may not be fair because...
Read article
January 15, 2023
Multivitamins proven to improve brain health!
January 15, 2023
Daily multivitamin use was compared to cocoa extract in more than 2,200 people over 65. After three years, taking a cocoa extract had no benefit while taking a multivitamin led to a significantly slower age-related cognitive...
Read article
January 11, 2023
Attend an excellent headache course for health care providers in San Diego
January 11, 2023
Opportunities & Challenges in the Management of Headache is one of the two annual courses organized by the Diamond Headache Clinic Research & Educational Foundation. This year, it will be held in San Diego from February...
Read article
January 7, 2023
Botox for trigeminal neuralgia due to multiple sclerosis
January 7, 2023
Botox has been shown to relieve the pain of trigeminal neuralgia (TN). TN is an excruciatingly painful and debilitating condition. The most common cause of TN is compression of the trigeminal nerve by a blood...
Read article
December 18, 2022
Go ahead, have a drink. Science proves that it won’t give you a migraine.
December 18, 2022
Holidays are again upon us. There are many reasons why people experience more migraines this time of year. Family drama, all the delicious unhealthy food, and alcohol. A report just published in the journal Headache brings...
Read article
December 5, 2022
Strength training vs aerobic exercise for migraine
December 5, 2022
Multiple posts on this blog have described clinical trials that prove the benefit of exercise for the prevention of migraine headaches.In a recent paper published in The Journal of Headache and Pain Stanford researchers compared...
Read article
November 25, 2022
Cognitive impairment due to migraine
November 25, 2022
According to a new report by Spanish researchers published in The Journal of Headaches and Pain, effective preventive treatment of migraines can improve cognitive impairment in patients with frequent attacks...
Read article
November 20, 2022
Thiamine (vitamin B1) may be more effective for migraines than riboflavin (vitamin B2)
November 20, 2022
Riboflavin (vitamin B2) has been a popular supplement for the prevention of migraine headaches. The evidence for its efficacy is limited. Only one small double-blind, placebo-controlled trial showed that a very high dose of riboflavin...
Read article
November 14, 2022
Microdosing for chronic pain
November 14, 2022
Psychedelics are being actively studied for depression and post-traumatic stress disorder (PTSD). These trials usually involve hallucinogenic doses. Microdosing psychedelic substances such as psilocybin, lysergic...
Read article
November 7, 2022
Acupuncture relieves chronic tension-type headaches
November 7, 2022
A recent study by Chinese researchers showed that acupuncture is an effective treatment for tension-type headaches. The results were published in a leading neurology journal, Neurology. Being published in such a journal...
Read article
October 29, 2022
The 6th Annual International Headache Symposium in Israel
October 29, 2022
It was an honor to speak in Israel at the 6th Annual International Headache Symposium along with past presidents of the International Headache Society, Drs. Messoud Ashina and Alan Rapaport, the current IHS president, Cristina...
Read article
October 15, 2022
The 2nd edition of The End of Migraines, 150 Ways to Stop Your Pain was just published
October 15, 2022
The second updated and expanded edition of The End of Migraines, 150 Ways to Stop Your Pain is now available on Amazon.com. The book is available as an ebook, paperback and hardcover. I would recommend getting the Kindle...
Read article
October 5, 2022
How to treat nummular headache
October 5, 2022
Nummular (coin-shaped) headache is an uncommon condition. It is defined as intermittent or continuous pain in a small circumscribed area of the scalp with the following four characteristics: sharply-contoured...
Read article
September 26, 2022
Exercise prevents not only migraines but also shrinkage of the brain
September 26, 2022
Regular exercise has been proven to prevent migraine headaches in many studies. A Swedish study of 91 patients established that exercising for 40 minutes 3 times a week is as effective as relaxation training or taking a...
Read article
September 8, 2022
Daxxify, a new Botox competitor
September 8, 2022
No, Daxxify is not really a competitor in the treatment of chronic migraines or any other medical condition. Daxxify, a new botulinum toxin, was just approved by the FDA only for cosmetic use. Daxxify does stand out from five other...
Read article
August 19, 2022
Post-COVID headaches
August 19, 2022
Headache is a common symptom of any infectious illness, including COVID. A group of Spanish researchers analyzed six published studies of headaches in adult Spanish COVID patients. According to their review, headache...
Read article
August 8, 2022
If the effect of Botox does not last 3 months, taking a zinc supplement might help.
August 8, 2022
Dr. Brian Loftus, a Texas neurologist, alerted me to the possibility that the shortening of the effect of Botox can be reversed by taking a zinc supplement. Dr. Loftus shared an unpublished report by Houston physicians who...
Read article
July 30, 2022
Migraine patients stick with Botox longer than with injections of CGRP mAbs
July 30, 2022
Patients with chronic migraine who were started on Botox were significantly more likely to continue to be treated with Botox after one year than patients who were started on a CGRP monoclonal antibody (mAb). mAbs are given...
Read article
July 18, 2022
Rimegepant for trigeminal neuralgia: a case report
July 18, 2022
A case report presented at the annual meeting of the American Headache Society described a patient with trigeminal neuralgia (TN) whose pain responded well to rimegepant (Nurtec). Rimegepant is a drug approved...
Read article
July 11, 2022
Magnesium and migraines – an interview with Dr. Amelia Scott Barrett
July 11, 2022
Last week I spoke to Dr. Amelia Scott Barrett, a neurologist and headache specialist based in Denver. She shares my interest in combining medications with various non-drug therapies. In our first conversation, we discussed...
Read article
July 6, 2022
The 6th Annual International Headache Symposium in Israel
July 6, 2022
The 6th Annual International Headache Symposium in Israel will be held at Daniel Hotel, Herzliya (8 miles from Tel Aviv), on October 27, 2022. THe symposium is organized by the President of the Israeli Headache Association...
Read article
June 27, 2022
Intravenous magnesium prevents migraines in children
June 27, 2022
Regular intravenous infusions of magnesium prevented migraines in five children, according to a report presented at the annual meeting of the American Headache Society by A.J. Freed and S. Sahai-Srivastava. The children...
Read article
June 20, 2022
Acute migraine therapy in pregnancy – triptan is the safest choice.
June 20, 2022
Two out of three women stop having migraines during pregnancy, especially in the second and third trimester. The difficult question is how to treat migraines in the first trimester and in women whose migraines do not...
Read article
June 11, 2022
Cove presents its data on the efficacy of telemedicine in treating migraines
June 11, 2022
With tens of millions of Americans suffering from migraines, access to care is a major problem. Cove, a telemedicine startup, offers a practical and affordable solution. They deliver evidence-based therapies to patients in need...
Read article
June 10, 2022
Triptans are safe even in those with cardiovascular conditions – a new report
June 10, 2022
A paper presented at the annual meeting of the American Headache Society that is taking place this weekend examined the risk of major adverse cardiovascular events (MACE) in patients with preexisting cardiovascular...
Read article
June 4, 2022
Another study confirms vascular safety of triptans
June 4, 2022
Sumatriptan (Imitrex) and other triptans have been available without a prescription in all European countries for over a decade. A new study by Austrian researchers published in the current issue of Headache confirms the outstanding...
Read article
May 22, 2022
Primary stabbing headache
May 22, 2022
Primary stabbing headache is a rare disorder. Because it is rare, it is often misdiagnosed and not treated properly. This post was prompted by a patient with this condition I saw last week. She went undiagnosed for 45 years...
Read article
May 9, 2022
CGRP monoclonal antibodies in pregnancy
May 9, 2022
Not surprisingly, none of the new migraine drugs have been tested in pregnant women. No new drug for any indication is ever tested for its safety in human pregnancy. They are always tested in pregnant animals, which helps...
Read article
May 2, 2022
Rimegepant (Nurtec) is now approved in Europe
May 2, 2022
Rimegepant (Nurtec ODT) was just approved by the European Medicines Agency for marketing in 27 EU countries as well as Iceland, Liechtenstein, and Norway. It was approved for both the acute treatment of migraine...
Read article